Literature DB >> 2090475

Effect of smoking on the lipid composition of lung lining fluid and relationship between immunostimulatory lipids, inflammatory cells and foamy macrophages in extrinsic allergic alveolitis.

D A Hughes1, P L Haslam.   

Abstract

Normal lung lining fluid suppresses lymphoproliferative responses. This effect is mediated by the major phospholipid components, but minor lipid components can stimulate lymphocyte proliferation. The aim of this study was to discover whether the changes in lung lipid composition reported in patients with extrinsic allergic alveolitis (EAA) might influence the levels of lymphocytes which occur in the lungs of these patients. Since cigarette smokers are less susceptible to EAA, we also investigated the effect of smoking on the lipid composition of lung lining fluid. Lung lining fluid was sampled by bronchoalveolar lavage (BAL) from 15 patients with EAA, and 9 non-smokers and 13 smokers without lung disease. The smoking controls had increases in phosphatidylethanolamine, sphingomyelin and phosphatidylglycerol, but lower levels of cholesterol and cholesterol:total phospholipid ratios compared with the nonsmoking controls. By contrast, the patients with EAA had increases in total phospholipid and sphingomyelin; there were no smoking related decreases in cholesterol; and several patients had levels of cholesterol and cholesterol:total phospholipid ratios above the upper limit for the controls. In the BAL fluids of the EAA patients, the levels.ml-1 of the immunostimulatory lipids sphingomyelin, phosphatidylethanolamine, cholesterol and cholesterol esters correlated with the number.ml-1 of lymphocytes, mast cells, neutrophils and "foamy" macrophages. Cholesterol levels (rs = 0.82) and lymphocyte counts (rs = 0.90) correlated most closely with "foamy" macrophages (p less than 0.001), suggesting that uptake of cholesterol by macrophages may enhance antigen-presenting function. These observations provide some support for the hypothesis that inflammatory reactions in the lungs might be influenced by the local lipid environment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2090475

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis.

Authors:  D A Hughes; P J Townsend; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

2.  Early effects of short-time cigarette smoking on the human lung: a study of bronchoalveolar lavage fluids.

Authors:  N M Mancini; M C Béné; H Gérard; F Chabot; G Faure; J M Polu; O Lesur
Journal:  Lung       Date:  1993       Impact factor: 2.584

3.  Surfactant lipidomics in healthy children and childhood interstitial lung disease.

Authors:  Matthias Griese; Hannah G Kirmeier; Gerhard Liebisch; Daniela Rauch; Ferdinand Stückler; Gerd Schmitz; Ralf Zarbock
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

Review 4.  Metabolic Functions of the Lung, Disorders and Associated Pathologies.

Authors:  Alcibey Alvarado; Isabel Arce
Journal:  J Clin Med Res       Date:  2016-08-30

5.  The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD.

Authors:  Miranda P Ween; Jake B White; Hai B Tran; Violet Mukaro; Charles Jones; Matthew Macowan; Gregory Hodge; Paul J Trim; Marten F Snel; Sandra J Hodge
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

6.  Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients.

Authors:  Antoine Moui; Stéphanie Dirou; Christine Sagan; Renan Liberge; Claire Defrance; Pierre-Paul Arrigoni; Olivier Morla; Christine Kandel-Aznar; Laurent Cellerin; Arnaud Cavailles; Emmanuel Eschapasse; Florent Morio; Pierre-Antoine Gourraud; Thomas Goronflot; Adrien Tissot; François-Xavier Blanc
Journal:  BMC Pulm Med       Date:  2022-03-05       Impact factor: 3.317

7.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

Review 8.  Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Authors:  Grith L Sorensen
Journal:  Front Med (Lausanne)       Date:  2018-02-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.